- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01034761
Using Clinical Alerts to Decrease Inappropriate Medication Prescribing
Using Clinical Alerts in a Computerized Provider Order Entry System to Decrease Inappropriate Medication Prescribing Among Hospitalized Elders
Introduction:
The Beers list identifies medications that should be avoided in persons 65 years or older because they are ineffective, pose an unnecessarily high risk, or a safer alternative is available. In a recent study, we found a high rate of prescribing of Beers list medications to hospitalized patients. At Baystate, 41% of medical patients received at least one Beers list drug classified as "high severity," meaning it carried a high risk for an adverse drug reaction, while 5% received 3 or more. Some Beers drugs have been associated with delirium and falls. When compared to Baystate patients who did not receive a high severity medication, those who did had an increased risk of mortality (7.8% vs. 5.2%), longer length of stay (5.5 days vs. 3.9 days) and higher costs ($11,240 vs. 6243).
Specific Aims:
- Quantify the impact of synchronous electronic alerts on physician prescribing of high-severity Beers' list drugs to hospitalized patients over the age of 65 years.
- Compare physician reactions to each drug-specific alert
Project Description:
We will develop a series of clinical alerts in CIS, Baystate's computerized provider order entry system, to reduce the use of potentially inappropriate medications among hospitalized elders. We will randomize providers to electronic alerts or usual care. Whenever a provider randomized to alerts attempts to place an order for a high-risk medication on the Beers list and the intended recipient is over 65 years of age, a synchronous alert (i.e. a "pop-up") will inform the physician about the risks associated with the medication and will propose safer alternatives.
We will collect data on physician ordering and patient outcomes comparing the number of Beers list prescriptions from providers receiving electronic alerts to those not receiving alerts. Our anticipated outcome is a decrease in inappropriate prescribing during the period when the electronic alerts are activated. Other potential outcomes include decrease in length of stay and a decrease in falls.
Aperçu de l'étude
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Massachusetts
-
Springfield, Massachusetts, États-Unis, 01199
- Baystate Medical Center
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Hospitalized patients with Age > 65
Exclusion Criteria:
- None
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Aucune intervention: Soins habituels
|
|
|
Expérimental: Pop-up alerts
Providers will receive pop-up alerts in the electronic medical record when prescribing one of the specified medications from the Beers list.
|
Pop-up alert in the electronic medical record whenever the provider enters an order for a specified high risk medication from the Beers list.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
The percentage of elderly patients who receive a specified high-risk medication from the Beer's list.
Délai: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
The average number of specified high risk medications prescribed per patient.
Délai: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
|
Restraint use
Délai: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
|
Falls
Délai: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
|
Length of stay
Délai: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
|
Total Cost
Délai: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
|
Discharge status
Délai: 6 months
|
6 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Linda J Canty, MD, Baystate Medical Center
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- 132454
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Pop-up alert
-
Hopital FochComplété
-
Children's Healthcare of AtlantaEmory UniversityComplétéAnxiété préopératoire pédiatrique, adaptation pédiatriqueÉtats-Unis
-
University Of PerugiaComplétéIncontinence urinaire | Prolapsus des organes pelviensItalie
-
University of CincinnatiChildren's Hospital Medical Center, Cincinnati; The Kroger CompanyComplétéHypertension | Obésité | Modification du régime | HyperlipidémiesÉtats-Unis
-
Society for Gynecological Surgery in FinlandActif, ne recrute pasProlapsus des organes pelviensFinlande
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalComplétéProlapsus des organes pelviensTurquie
-
University Magna GraeciaRetiréProlapsus des organes pelviensItalie
-
Shannon E. Sauer-ZavalaNational Institute of Mental Health (NIMH)ComplétéTrouble obsessionnel compulsif | Troubles anxieux | Trouble de stress post-traumatiqueÉtats-Unis
-
Stanford UniversityComplétéThrombocytopénieÉtats-Unis
-
Andalas UniversityFaculty of Medicine, Andalas University; Dr. M Djamil Hospital, PadangRecrutementChirurgie vaginale du prolapsus des organes pelviens | Injection de plasma riche en plaquettesIndonésie